ALK inhibitor - PDFSEARCH.IO - Document Search Engine

ALK inhibitor
Results: 36

#	Item
11	PDF Document Add to Reading List Source URL: www.amp.org Language: English - Date: 2010-11-01 17:47:52 Biology ALK inhibitor Organofluorides Crizotinib Anaplastic lymphoma kinase Anaplastic large-cell lymphoma Non-small-cell lung carcinoma ALK Inflammatory myofibroblastic tumour Medicine Lung cancer Chemistry
12	Vysis ALK Break Apart FISH Probe Kit en 06N38-020 Add to Reading List Source URL: www.abbottmolecular.com Language: English - Date: 2011-09-27 17:26:22 Molecular biology Microscopy Cytogenetics Genetics Fluorescence in situ hybridization Microscope slide Staining ALK inhibitor In situ hybridization Biology Chemistry Laboratory techniques
13	Public Summary Document Application No[removed] – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-16 01:23:53 Lung cancer Organofluorides Organochlorides Anatomical pathology Crizotinib Pyrazoles Non-small-cell lung carcinoma Anaplastic lymphoma kinase ALK inhibitor Medicine Chemistry Oncology
14	Microsoft Word[removed]FinalPSD-ALKtestingforcrizotinib-Nov2014update-accessible.DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-16 01:23:53 Lung cancer Organofluorides Organochlorides Anatomical pathology Crizotinib Pyrazoles Non-small-cell lung carcinoma Anaplastic lymphoma kinase ALK inhibitor Medicine Chemistry Oncology
15	ACTIVITY OF THE HSP90 INHIBITOR, AT13387, IN ALK-DRIVEN TUMOR MODELS. Nicola Wallis, Tomoko Smyth, Joanne Munck, Ana Rodriguez-Lopez, Victoria Lock, Rachel McMenamin, Neil Thompson & John Lyons Astex Pharmaceuticals, 436 Add to Reading List Source URL: astx.com Language: English - Date: 2012-12-17 16:09:22 Organofluorides Oncology Crizotinib Piperidines Pyrazoles Pyridines ALK inhibitor Anaplastic lymphoma kinase Non-small-cell lung carcinoma Lung cancer Medicine Chemistry
16	THE HSP90 INHIBITOR, AT13387, IS EFFECTIVE IN MUTANT EGFR AND ALK-POSITIVE NSCLC MODELS. Tomoko Smyth, Ana Rodriguez-Lopez, Rachel McMenamin, Victoria Lock, Jayne Curry, Brent Graham, John Lyons, Neil Thompson and Nicola Add to Reading List Source URL: astx.com Language: English Organochlorides Amines Quinazolines Pfizer Gefitinib Crizotinib Protein kinase inhibitor ALK inhibitor Hsp90 Chemistry Organic chemistry Organofluorides
17	Public Summary Document Application No[removed] – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib Add to Reading List Source URL: www.msac.gov.au Language: English Lung cancer Organofluorides Organochlorides Anatomical pathology Crizotinib Pyrazoles Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Oncology Chemistry
18	1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:14 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Chemistry Oncology
19	Public Summary Document Application No. 1250 – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Anatomical pathology Organofluorides Organochlorides Pfizer Crizotinib Anaplastic lymphoma kinase Non-small-cell lung carcinoma Protein kinase inhibitor Squamous-cell carcinoma Medicine Oncology Lung cancer
20	1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-03-20 01:49:45 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Chemistry Oncology